2023年10月9日 · Memantine is marketed for the treatment of moderate to severe Alzheimer's disease in the United States, Canada, Europe, China, and other countries, and for the treatment of dementia in Germany, where it has been on the market since 1989 under the name Akatinol. Memantine received European marketing approval in 2002 and U.S. FDA approval in 2003.

Back to the Top. Find a Therapeutic By Name Go NSC001 AAB-003 AADvac1 AAV-GAD AAV2-BDNF ABBV-0805 ABBV-552 ABBV-916 ABBV-CLS-7262 ABT 418 ABT-089 ABT-288 ABT-384 ABT-957 ABvac40 ACD856 Acetyl-l-carnitine HCI ACI-24.060 ACI-3024 ACI-35 ACI-7104.056 Acitretin ACP-204 Aduhelm AF 102B Affitope AD02 AGB101 AKST4290 AL002 AL003 AL044 AL101 Allopregnanolone ALN-APP ALPHA-1062 Alpha-Tocopherol ALX-001 ...

Akatinol®, Memary® Alzheimer's Disease (Approved) Forest Laboratories, Inc., Lundbeck, Merz Pharma: Other Neurotransmitters: Small Molecule: Alzheimer's Disease: Rivastigmine: Exelon™, Rivastigmine tartrate , Rivastach® Patch, Prometax®, SDZ ENA 713: Alzheimer's Disease (Approved), Parkinson's Disease Dementia (Approved) Novartis ...

Akatinol®, Memary® Alzheimer's Disease (Approved) Forest Laboratories, Inc., Lundbeck, Merz Pharma: Other Neurotransmitters: Small Molecule: Alzheimer's Disease: Metformin : Glucophage, Glucophage XR: Alzheimer's Disease (Phase 2/3) Other: Small Molecule: Type 2 Diabetes: Methylphenidate: Ritalin, Concerta: Alzheimer's Disease (Phase 4) Other ...

Name Synonyms FDA Status Company Target Type Therapy Type Approved For; AAB-003: PF-05236812: Alzheimer's Disease (Discontinued)